María Blasco Marhuenda

article - María Blasco Marhuenda

María Antonia Blasco Marhuenda (born 1965), known as María Blasco, is a Spanish molecular biologist. She is the current director of the Spanish National Cancer Research Centre (Centro Nacional de Investigaciones Oncológicas, CNIO).

This biographical article is written like a résumé. (May 2020)
Spanish scientist
In this Spanish name, the first or paternal surname is Blasco and the second or maternal family name is Marhuenda.
María Blasco
Born
María Antonia Blasco Marhuenda

1965 (age 5556)

Nationality Spanish
Alma mater Universidad de Valencia, BSc Universidad Autónoma de Madrid, PhD
Awards EMBO Gold Medal (2004)
Scientific career
Fields Molecular biology
Institutions Spanish National Cancer Research Centre

. . . María Blasco Marhuenda . . .

Blasco was born in 1965. She obtained her PhD in 1993 for her research at the Centro de Biología Molecular Severo Ochoa (UAMCSIC), under the supervision of Margarita Salas. That same year, Blasco joined the Cold Spring Harbor Laboratory in New York (USA) as a Postdoctoral Fellow under the leadership of Carol W. Greider (who was to win a Nobel Prize in 2009). In 1997 she returned to Spain to start her own research at the Centro Nacional de Biotecnología in Madrid. She joined the Centro Nacional de Investigaciones Oncológicas (CNIO) in 2003 as Director of the Molecular Oncology Programme and Leader of the Telomeres and Telomerase Group. In 2005 she was also assigned as Vice-Director of Basic Research and in 2011 she was appointed as CNIO Director.[1][2]

  • Isolation of the core components of mouse telomerase and generation of the first knockout mouse for telomerase;[3]
  • Generation of the first mouse with increased telomerase expression in adult tissues;[4]
  • The finding that mammalian telomeres and subtelomeres have epigenetic marks characteristic of constitutive heterochromatin;[5]
  • Discovery of telomeric RNAs, which are potent telomerase-inhibitors whose expression is altered in cancer;[6]
  • Demonstration that telomerase activity and telomere length determine the regenerative capacity of adult stem cells;[7]
  • Identification of the longest telomeres as a universal feature of adult stem cell niches;[8]
  • The finding that telomerase overexpression in the context of cancer resistant-mice improves organismal fitness, produces a systemic delay in ageing and an extension in median life-span;[9]
  • Discovery that telomeres rejuvenate after nuclear reprogramming;
  • Identification of the molecular mechanisms by which short telomeres/DNA damage limit nuclear reprogramming of defective cells;[10]
  • Discovery that telomeric protein TRF1 can act as both a tumour suppressor and as a factor in ageing prevention.[11]

. . . María Blasco Marhuenda . . .

This article is issued from web site Wikipedia. The original article may be a bit shortened or modified. Some links may have been modified. The text is licensed under “Creative Commons – Attribution – Sharealike” [1] and some of the text can also be licensed under the terms of the “GNU Free Documentation License” [2]. Additional terms may apply for the media files. By using this site, you agree to our Legal pages . Web links: [1] [2]

. . . María Blasco Marhuenda . . .

© 2022 The Grey Earl INFO - WordPress Theme by WPEnjoy